3.26.1 html 155 213 1 false 49 0 false 7 false false R1.htm 75000 - Document - Document and Entity Information Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 75010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 75020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 75030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 75040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 5 false false R6.htm 75050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) Statements 6 false false R7.htm 75060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT EQUITY (Unaudited) (Parenthetical) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersDeficitEquityUnauditedParenthetical CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT EQUITY (Unaudited) (Parenthetical) Statements 7 false false R8.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 8 false false R9.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 9 false false R10.htm 995455 - Disclosure - Nature of Business and Significant Accounting Policies Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureNatureOfBusinessAndSignificantAccountingPolicies Nature of Business and Significant Accounting Policies Notes 10 false false R11.htm 995485 - Disclosure - Collaboration Agreements Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureCollaborationAgreements Collaboration Agreements Notes 11 false false R12.htm 995495 - Disclosure - Fair Value Measurements Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 995505 - Disclosure - Cash and Cash Equivalents Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureCashAndCashEquivalents1 Cash and Cash Equivalents Notes 13 false false R14.htm 995535 - Disclosure - Leases Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureLeases Leases Notes 14 false false R15.htm 995545 - Disclosure - Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAccruedExpensesAndOtherCurrentLiabilities Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities Notes 15 false false R16.htm 995565 - Disclosure - Grant Agreement Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureGrantAgreement Grant Agreement Notes 16 false false R17.htm 995575 - Disclosure - Net Loss per Share Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureNetLossPerShare Net Loss per Share Notes 17 false false R18.htm 995585 - Disclosure - Equity Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureEquity Equity Notes 18 false false R19.htm 995595 - Disclosure - Segment Information Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureSegmentInformation Segment Information Notes 19 false false R20.htm 995605 - Disclosure - Subsequent Events Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 20 false false R21.htm 995615 - Disclosure - Nature of Business and Significant Accounting Policies (Policies) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureNatureOfBusinessAndSignificantAccountingPoliciesPolicies Nature of Business and Significant Accounting Policies (Policies) Policies http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureNatureOfBusinessAndSignificantAccountingPolicies 21 false false R22.htm 995635 - Disclosure - Cash and Cash Equivalents (Tables) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureCashAndCashEquivalentsTables Cash and Cash Equivalents (Tables) Tables http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureCashAndCashEquivalents1 22 false false R23.htm 995655 - Disclosure - Leases (Tables) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureLeasesTables Leases (Tables) Tables http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureLeases 23 false false R24.htm 995665 - Disclosure - Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities (Tables) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAccruedExpensesAndOtherCurrentLiabilitiesTables Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities (Tables) Tables http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAccruedExpensesAndOtherCurrentLiabilities 24 false false R25.htm 995675 - Disclosure - Net Loss per Share (Tables) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureNetLossPerShareTables Net Loss per Share (Tables) Tables http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureNetLossPerShare 25 false false R26.htm 995685 - Disclosure - Equity (Tables) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureEquityTables Equity (Tables) Tables http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureEquity 26 false false R27.htm 995695 - Disclosure - Segment Information (Tables) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureSegmentInformationTables Segment Information (Tables) Tables http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureSegmentInformation 27 false false R28.htm 995705 - Disclosure - Nature of Business and Significant Accounting Policies - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureNatureOfBusinessAndSignificantAccountingPoliciesAdditionalInformationDetails Nature of Business and Significant Accounting Policies - Additional Information (Details) Details 28 false false R29.htm 995745 - Disclosure - Collaboration Agreements - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureCollaborationAgreementsAdditionalInformationDetails Collaboration Agreements - Additional Information (Details) Details 29 false false R30.htm 995755 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 30 false false R31.htm 995765 - Disclosure - Cash and Cash Equivalents - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureCashAndCashEquivalentsAdditionalInformationDetails Cash and Cash Equivalents - Additional Information (Details) Details 31 false false R32.htm 995775 - Disclosure - Cash and Cash Equivalents - Schedule of Cash and Cash Equivalents (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails Cash and Cash Equivalents - Schedule of Cash and Cash Equivalents (Details) Details 32 false false R33.htm 995815 - Disclosure - Leases - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 33 false false R34.htm 995825 - Disclosure - Leases - Components of Lease Expense (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureLeasesComponentsOfLeaseExpenseDetails Leases - Components of Lease Expense (Details) Details 34 false false R35.htm 995835 - Disclosure - Leases - Summary of Right of Use Assets Acquired Under Operating Leases (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureLeasesSummaryOfRightOfUseAssetsAcquiredUnderOperatingLeasesDetails Leases - Summary of Right of Use Assets Acquired Under Operating Leases (Details) Details 35 false false R36.htm 995845 - Disclosure - Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities - Summary of Prepaid Expenses and Other Current Assets (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAccruedExpensesAndOtherCurrentLiabilitiesSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities - Summary of Prepaid Expenses and Other Current Assets (Details) Details 36 false false R37.htm 995855 - Disclosure - Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAccruedExpensesAndOtherCurrentLiabilitiesSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDeta Prepaid Expenses, Other Current Assets, Accrued Expenses, and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details) Details 37 false false R38.htm 995865 - Disclosure - Reverse Stock Split - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureReverseStockSplitAdditionalInformationDetails Reverse Stock Split - Additional Information (Details) Details 38 false false R39.htm 995875 - Disclosure - Grant Agreement - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureGrantAgreementAdditionalInformationDetails Grant Agreement - Additional Information (Details) Details 39 false false R40.htm 995885 - Disclosure - Net Loss per Share - Computation of Basic and Diluted Net Loss per Share (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails3 Net Loss per Share - Computation of Basic and Diluted Net Loss per Share (Details) Details 40 false false R41.htm 995895 - Disclosure - Net Loss per Share - Summary of Potentially Dilutive Shares Excluded from Calculation of Net Loss Per Share (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureNetLossPerShareSummaryOfPotentiallyDilutiveSharesExcludedFromCalculationOfNetLossPerShareDetails Net Loss per Share - Summary of Potentially Dilutive Shares Excluded from Calculation of Net Loss Per Share (Details) Details 41 false false R42.htm 995905 - Disclosure - Equity - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/Role_DisclosureEquityAdditionalInformationDetails Equity - Additional Information (Details) Details 42 false false R43.htm 995915 - Disclosure - Equity - 2023 and 2024 Common Warrants - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureEquity2023And2024CommonWarrantsAdditionalInformationDetails Equity - 2023 and 2024 Common Warrants - Additional Information (Details) Details 43 false false R44.htm 995925 - Disclosure - Equity - 2024 Common Warrants - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureEquity2024CommonWarrantsAdditionalInformationDetails Equity - 2024 Common Warrants - Additional Information (Details) Details 44 false false R45.htm 995935 - Disclosure - Equity - 2025 Equity Offerings and Common Warrants - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureEquity2025EquityOfferingsAndCommonWarrantsAdditionalInformationDetails Equity - 2025 Equity Offerings and Common Warrants - Additional Information (Details) Details 45 false false R46.htm 995945 - Disclosure - Equity - Summary of Assumptions Used to Estimate the Fair Value of the Warrants Using The Black-scholes Option Pricing Model (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureEquitySummaryOfAssumptionsUsedToEstimateTheFairValueOfTheWarrantsUsingTheBlackscholesOptionPricingModelDetails Equity - Summary of Assumptions Used to Estimate the Fair Value of the Warrants Using The Black-scholes Option Pricing Model (Details) Details 46 false false R47.htm 995955 - Disclosure - Equity - 2026 Niowave Common Warrants - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureEquity2026NiowaveCommonWarrantsAdditionalInformationDetails Equity - 2026 Niowave Common Warrants - Additional Information (Details) Details 47 false false R48.htm 995965 - Disclosure - Equity - Standby Equity Purchase Agreement - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureEquityStandbyEquityPurchaseAgreementAdditionalInformationDetails Equity - Standby Equity Purchase Agreement - Additional Information (Details) Details 48 false false R49.htm 995975 - Disclosure - Equity - At The Market Offering Agreement - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureEquityAtTheMarketOfferingAgreementAdditionalInformationDetails Equity - At The Market Offering Agreement - Additional Information (Details) Details 49 false false R50.htm 995985 - Disclosure - Equity - Summary of Common Warrant Activity (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureEquitySummaryOfCommonWarrantActivityDetails Equity - Summary of Common Warrant Activity (Details) Details 50 false false R51.htm 995995 - Disclosure - Segment Information - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetails Segment Information - Additional Information (Details) Details 51 false false R52.htm 996005 - Disclosure - Segment Information - Summary of Significant Expense Categories (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureSegmentInformationSummaryOfSignificantExpenseCategoriesDetails Segment Information - Summary of Significant Expense Categories (Details) Details 52 false false R53.htm 996015 - Disclosure - Segment Information - Summary of Significant Asset Categories (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureSegmentInformationSummaryOfSignificantAssetCategoriesDetails Segment Information - Summary of Significant Asset Categories (Details) Details 53 false false R54.htm 996025 - Disclosure - Subsequent Events - Additional Information (Details) Sheet http://aptevotherapeutics.com/20260630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails Subsequent Events - Additional Information (Details) Details 54 false false All Reports Book All Reports apvo-20260630.htm apvo-20260630.xsd http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 false false